Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 12 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Method of generating integrated circuit model
Segmenting video based on timestamps in comments
Method and system for acquiring support capability of mobile terminal by base station side system
System and method for computational unification of heterogeneous implicit and explicit processing elements
Plants and seeds of corn variety CV092363
Nucleotide sequence coding for variable regions of .beta. chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses
System and method for associating financial transaction data with user's project data
  Randomly Featured Patents
Master information carrier for magnetic transfer
Wide chain link conveyor structure
Method and system for providing interface defaults
Digitally controlled ringer signal generation
Device providing compensation for acceleration sensitivity of an oscillator
Method and apparatus for manufacturing inorganic fiber through pendent process and apparatus for carrying out the same
Pyridone-methide azo dyestuffs
Home gateway expansion
Method and apparatus for enclosing a cable splice
Efficient low-latency buffer